Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of Lefenacin intermediate via reductive amination. Eliminates heavy metal risks, ensuring high purity and cost-effective API manufacturing for global supply chains.
Novel demethylation route achieves >99.8% purity without column chromatography. Ideal for opioid antagonist manufacturing with reduced costs and scalable production.
Patent CN105017358B reveals a novel sulfonylation route for Emamectin Benzoate offering significant cost reduction and supply chain reliability for agrochemical manufacturing partners.
Patent CN111807975A reveals a safer, cost-effective route for dobutamine intermediates using acetic acid catalysis and borohydride reduction, eliminating high-pressure hydrogenation risks.
Patent CN106754806B discloses a high-efficiency transaminase for synthesizing (R)-3-aminobutanol, offering superior substrate tolerance and eliminating organic cosolvents for cost-effective manufacturing.
Patent CN110551032B details a high-efficiency iridium-catalyzed asymmetric reductive amination method, offering significant cost reduction in agrochemical manufacturing and reliable supply chain solutions.
Novel three-step synthesis patent CN118638118A enables scalable production. Delivers high-purity pharmaceutical intermediates with optimized cost and supply chain reliability for global partners.
Patent CN106111189B reveals a novel chiral pyridoxamine catalyst enabling mild synthesis of alpha-amino acids with high ee values and scalable manufacturing potential.
Novel Lewis acid catalyzed reductive amination route offers >99% purity and scalable production for pharmaceutical intermediates.
Advanced reductive amination route for Etimicin precursor. High yield, simplified purification, scalable API intermediate manufacturing process.
Discover high-purity indole-dihydronaphthalene intermediates via novel Rh/Pd dual catalysis. Enhanced enantioselectivity and cost-effective manufacturing for pharma.
Patent CN101575321A details a nickel-catalyzed synthesis for trimetazidine, offering significant cost reduction and safety improvements over palladium or hydride methods for API intermediates.
Novel synthesis route for 3 6-diazabicyclo octane derivatives improves solubility and offers cost reduction in API manufacturing for global supply chains.
Novel nickel imine complex catalyzes cyclohexylacetylene hydroamination. High yield, mild conditions, cost-effective manufacturing solution.
Patent CN102782894B discloses stable hole transport materials for OLEDs. Enhance device lifetime and efficiency with our scalable electronic chemical manufacturing solutions.
Patent CN116514666A reveals a safer bromhexine hydrochloride synthesis. Achieve cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN113789310B reveals high-yield transaminase route for moxifloxacin intermediates, eliminating DMSO for cost-effective and scalable API manufacturing.
Novel water removal technique enhances purity and yield for veterinary drug manufacturing supply chains globally ensuring reliable high-quality intermediate production and significant cost reduction.
Patent CN113149937B enables high-purity 2,5-bis(aminomethyl)furan via one-pot catalysis. Offers renewable sourcing and simplified supply chain for global buyers.
Patent CN114573500A details a safer Fmoc-based synthesis for lefenacin intermediates, offering cost reduction in API manufacturing and enhanced supply chain reliability.